New GDP Rules in Russia - what you need to know
Recommendation

8 September 2026
Basel, Switzerland
Specifics in the Distribution of Medicinal Products
The new GDP rules published in Russia last year have been valid since 1 March 2017. They do of course apply to companies in Russia, but also pharmaceutical companies distributing to Russia should be aware of the new rules on storage and transportation. Companies operating in Russia are now also responsible for ensuring that any contract warehouses and other third party services do meet the same requirements.
So with these new rules which are similar to the EU and PIC/S GDP guidelines, pharmaceutical manufacturers, distributors and warehouses should check their existing quality systems and implement or provide for example:
- Initial and on-going training for all employees involved in GDP
- GDP compliant quality system and standard operating procedures in place
- GDP compliant documentation, record-keeping and reporting
- Separate storage areas for counterfeit medicines
- Appointing a person being responsible for implementing and maintaining the quality system and monitoring its compliance and efficiency
- Monitoring compliance of third party logistic providers and warehouses (including audits)
This Code of Good Practice in the Pharmaceutical Industry is also available in English.
Related GMP News
11.08.2026GDP for APIs: APIC Publishes Updated "How to Do" Document
11.08.2026Where to Find Information on UK Wholesale Authorisations
11.08.2026Call for Presentations: GDP Forum 2027 in Berlin
11.08.2026Questions and Answers from the ECA Webinar "GDP Update 2026" - Part 5
14.07.2026USP Proposes to Revise the Definition of Controlled Room Temperature in Chapter <659>
14.07.2026GDP in Hong Kong: Authority Provides Additional Information


